Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a long non-coding RNA identified as an antisense transcript overlapping or adjacent to the CPNE5 (Copine 5) locus. Antisense lncRNAs such as this can regulate the expression of their sense (protein-coding) partners by diverse mechanisms, including transcriptional interference (where the process of transcribing the antisense RNA impedes sense gene transcription), RNA masking (where the antisense RNA binds and alters processing or stability of the sense RNA), or by forming double-stranded RNA that leads to RNA interference or epigenetic changes. There is currently no evidence that this transcript encodes a protein or functions as a direct therapeutic target, nor is there information linking it to interacting drugs, specific biomarker roles, or safety concerns. Its functional annotation is typical for lncRNA/antisense transcripts, emphasizing regulatory potential rather than enzymatic, receptor, or transporter activity.
Transcriptional interference, RNA masking, dsRNA-dependent silencing (RNAi)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CPNE5.